NCT01277692 · Interventional trial
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Overall registry status Completed
Phase 1
Conditions Hepatitis C
Delaware Valley sites
- GSK Investigational Site · Willingboro, NJ · Burlington County
First posted
Registry updated
Added to the directory